KSP

company

About

KSP is the core business entity responsible for operating the Kanagawa Science Park and accepted the challenge of creating new industries.

  • 1001 - 5000

Highlights

Details

Industries
Finance,Financial Services,Human Resources
Founded date
Dec 1, 1986
Number Of Employee
1001 - 5000
Operating Status
Active
Investor Type
Venture Capital

KSP, Inc. is the core business entity responsible for operating the Kanagawa Science Park (KSP) and has accepted the challenge of creating new industries through the support, development, and incubation of venture businesses. We provide a variety of business support services that best meet the needs of venture businesses in each stage of their business growth, ranging from the processes of startup and growth to public offerings. Several hundreds of new startup companies have been created and nurtured since its foundation.

An incubation manager (IM) acts as a coordinator and provides a variety of support services to a venture company to help them successfully launch and develop their new business, such as offering individual consultations and a variety of information or advice. KSP, Inc. is well poised to cope with the varying needs of new ventures for highly sophisticated, specialized tasks by offering a business school, business support center, business matching services, and investment funds.

The public sector, such as the Kanagawa prefectural government, Kawasaki city government, and the Development Bank of Japan, Inc., has an equity participation in KSP, thus playing a vital role in the deployment of local industrial development policy.

Investments

Number of Investments
Number of Lead Investments
4
0
KSP has made 4 investments. Their most recent investment was on Nov 21, 2019, when Luxonus raised ¥600M.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 21, 2019 Luxonus
Series A ¥600M Manufacturing
Dec 28, 2018 StemRIM
Series Unknown ¥745.02M Biotechnology
Aug 30, 2018 Miraikikai
Series Unknown ¥700M Consumer Electronics
Nov 17, 2017 StemRIM
Series Unknown ¥1B Biotechnology